CONCLUSIONS
• Approximately half of the OP population met increased risk definition criteria, yet despite being at increased risk of fracture less than half were receiving an approved therapy for OP.
• The German DVO guidelines/criteria identify patients at a considerable risk of having an imminent fracture (ie. a fracture that would occur in the next 12 months).
• Increased risk of fracture was confirmed to be associated with greater burden on the healthcare systems and increased related health care costs. The higher disease burden and costs were not attributable to comorbid conditions, which were similar between those at increased risk and those not.
BACKGROUND
• Individuals at increased risk of fracture can be identified by several tools such as FRAX or other combinations of risk factors. However, these tools provide the estimate of fracture risk over a lengthy (10 year) period of time.
• Identifying patients at imminent risk (those in whom fracture is likely to occur within 12-24 months) has clear value for prioritizing treatment strategies.
• The German DVO guidelines 1 provide a list of clinical and treatmentrelated risk factors to identify patients who are at increased risk of osteoporotic fracture (Box 1).
• This research was conducted to assess and confirm risk factors identified in the DVO guidelines using real-world data; and describe the level of imminent facture risk within the increased risk group.
METHODS

Study Design
• Observational study using retrospective German sick fund data (~5% of the population) for the years 2009-2011.
• The sample was defined based on 2010 data (baseline period) while the study investigational year was 2011.
Patients
• Women aged ≥50 were defined to suffer from osteoporosis (OP) if they had an osteoporotic diagnostic code in the baseline period.
• Following DVO guidelines, osteoporotic women were considered to be at increased risk (IR) of fracture if they fulfilled any of the following conditions in the baseline period: − ≥1 prescription for an anti-resorptive/anabolic agent not associated to an alternative, non-OP indication or diagnosis (eg. Paget disease, malignancy) − a history of osteoporotic fracture (diagnostic code M80 and/or a diagnostic code for a fracture) − ≥1 clinical or treatment-related additional risk factor according to DVO guidelines.
• Osteoporotic women not meeting any of these criteria were considered non-increased risk (N-IR).
Assessment of Fractures
• Incident fractures (regardless of etiology) were identified using ICD codes S22, S32, S42, S52, S72 and S82; outpatient diagnoses were used for S22, S32, S52 and S82, inpatient diagnoses were used for femur fractures (S72) as they would require hospital treatment.
• To avoid double-counting, a re-fracture of the same site required ≥6 months (outpatient) or ≥7 months (inpatient) between codes.
• The proportion of fractures attributable to osteoporosis was estimated using the approach suggested by Brecht and Schädlich, 2 in line with previous epidemiological studies.
Medical Resource Utilization and Cost
• Inpatient and outpatient costs were attributed to OP if there was an OP diagnostic code (M80, M81), one of the fracture codes listed above or a pre-specified treatment typically associated with OP or fractures (eg. fracture healing).
• For medication, a list of anti-resorptive/anabolic OP agents was defined which could directly be attributed to OP (patients taking these drugs for alternative indications were already excluded).
• Descriptive analyses on OP-related medical resource utilization, fracture frequency and osteoporosis related costs were performed.
RESULTS
• Among 74,974 women who were diagnosed or treated for OP, 39,969 (53.3%) were identified as being at increased risk for fracture ( Figure 1 ). • Women with IR had a mean age of 75.2 (SD 9.5) years and were only slightly older than N-IR women (74.0, SD 10.1 years).
• The most frequent comorbidities in IR patients were hypertension (70%) and lipid disorders (44%) (Figure 3 ). • Incident fracture events were frequently observed in IR patients, the most frequent being vertebral fractures (Figure 2 ).
• After applying the algorithm of Brecht and Schädlich for the estimation of fractures attributable to OP, the incidence of fractures remained high in IR patients (16 events per 100 patients) (Figure 2 ).
• The higher prescription of OP drugs and the higher OP-related utilization and fracture rates in IR patients translated into substantial differences in OP-related healthcare cost (Table 1) : − IR patients had higher mean medical expenses related to OP care. − Most of the cost was related to taking care of fractures in the inpatient setting. 
